EMMA News and Press, Emmaus Life Sciences Incorporation From 08/15/22

Emmaus Life Sciences press release ( OTCQX:EMMA ): Q2 GAAP EPS of -$0.18. Revenue of $4.3M misses by $1.7M . At June 30, 2022, the company had cash and cash equivalents of $1.0 million For further details see: Emmaus Life Sciences GAAP EPS of -$0.18, revenue ...

Emmaus Life Sciences Reports Q2 2022 Financial Results and Provides Business Update PR Newswire TORRANCE, Calif. , Aug. 15, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in ...

Emmaus Life Sciences Announces Engagement of Strategic Business Relations and Professional Services Advisor PR Newswire Acorn Management Partners Will Develop and Implement a Market Awareness Program Targeting Financial Professionals TORRANCE, Calif. , ...

Vancouver, Kelowna, Delta, BC - July 8, 2022 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Mining, Biotech, eSport and Plant-Based. Today's stocks have been added to our lists of fr...

NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the June 23 r d Life Sciences Investor Forum are now available for on-demand viewing. REGISTER NOW OR LOG...

NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, in partnership with Zacks Small-Cap Research, today announced the agenda for the upcoming Life Sciences Investor Forum to be held on June 23 rd . Individual inve...

Emmaus Life Sciences press release (OTCPK:EMMA): Q1 GAAP EPS of -$0.03. Revenue of $3.23M (-39.4% Y/Y) misses by $2.77M. For further details see: Emmaus Life Sciences GAAP EPS of -$0.03, revenue of $3.23M misses by $2.77M

Emmaus Life Sciences Reports Q1 2022 Financial Results and Provides Business Update PR Newswire TORRANCE, Calif. , May 13, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA) , a commercial-stage biopharmaceutical company and leader in ...

Emmaus Life Sciences to Present at Investor Conferences in May PR Newswire TORRANCE, Calif. , April  26, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of s...

Emmaus Life Sciences (OTCPK:EMMA) notifies the launch of an innovative full-service telehealth solution accompanied by strategic partners, including Asembia LLC, US Bioservices Corporation and UpScript IP Holdings, LLC. The platform providers will handle on-line prescribing, dispensing a...